Smart-4-Fabry is the acronym of a H2020 funded Project
that stands for “Smart functional GLA-nanoformulation
for Fabry disease”. Smart-4-Fabry is a collaborative project
funded under the H2020 EU Research
and Innovation programme.

The project started on
the 1st January 2017 and will last four years.



Old news


  • Vall d’hebron Seminar - Lysosomal Disorders: focus on Fabry Disease

    19.11.2018  8:30 am - 6:00 pm
    Vall d'Hebron, 08035 Barcelona, España

    Genetic deficiencies of lysosomal components, most commonly enzymes, are known as"lysosomal storage disorders" (LSDs) and lead to lysosomal dysfunction, broadly affecting peripheral organs and the central nervous system, debilitating patients and frequently causing fatality. This seminar will update clinicians and researchers on most recent advances in diagnosis, pathophysiology and management of Fabry disease as well as in emergingtherapies in the treatment of LSD.  This seminar is supported by Smart4Fabry project

    See more details